| Bullous pemphigoid in infants: characteristics, diagnosis and treatment A Schwieger-Briel, C Moellmann, B Mattulat, F Schauer, D Kiritsi, ... Orphanet journal of rare diseases 9, 1-12, 2014 | 88 | 2014 |
| Information needs of people with rare diseases-what information do patients and their relatives require S Litzkendorf, A Babac, D Rosenfeldt, F Schauer, T Hartz, V Lührs, ... J Rare Dis Diagn Ther 2 (2), 40, 2016 | 49 | 2016 |
| Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study A Reimer, M Hess, A Schwieger‐Briel, D Kiritsi, F Schauer, H Schumann, ... British Journal of Dermatology 182 (6), 1437-1448, 2020 | 44 | 2020 |
| The position of targeted next-generation sequencing in epidermolysis bullosa diagnosis C Has, J Küsel, A Reimer, J Hoffmann, F Schauer, A Zimmer, J Fischer Acta dermato-venereologica 98 (4), 437-440, 2018 | 42 | 2018 |
| Skin inflammation associated with arthritis, synovitis and enthesitis. Part 2: rheumatoid arthritis, reactive arthritis, Reiter's syndrome, Lyme borreliosis, dermatomyositis … CM Schempp, F Schauer, CK Huhn, N Venhoff, S Finzel JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17 (2), 167-181, 2019 | 32 | 2019 |
| Targeting epidermal lipids for treatment of Mendelian disorders of cornification D Kiritsi, F Schauer, U Wölfle, M Valari, L Bruckner-Tuderman, C Has, ... Orphanet journal of rare diseases 9, 1-7, 2014 | 31 | 2014 |
| Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa D Kiritsi, K Dieter, E Niebergall-Roth, S Fluhr, C Daniele, J Esterlechner, ... JCI insight 6 (22), 2021 | 28 | 2021 |
| Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study JS Kern, E Sprecher, MF Fernandez, F Schauer, C Bodemer, ... British Journal of Dermatology 188 (1), 12-21, 2023 | 23 | 2023 |
| Use and importance of different information sources among patients with rare diseases and their relatives over time: a qualitative study S Litzkendorf, M Frank, A Babac, D Rosenfeldt, F Schauer, T Hartz, ... BMC public health 20, 1-14, 2020 | 21 | 2020 |
| Evaluation of nomacopan for treatment of bullous pemphigoid: a phase 2a nonrandomized controlled trial CD Sadik, H Rashid, CM Hammers, GFH Diercks, A Weidinger, S Beissert, ... Jama dermatology 158 (6), 641-649, 2022 | 20 | 2022 |
| Esophageal lichen planus: towards diagnosis of an underdiagnosed disease F Schauer, C Monasterio, K Technau-Hafsi, JS Kern, A Lazaro, P Deibert, ... Scandinavian Journal of Gastroenterology 54 (10), 1189-1198, 2019 | 20 | 2019 |
| Adopting quality criteria for websites providing medical information about rare diseases F Pauer, J Göbel, H Storf, S Litzkendorf, A Babac, M Frank, V Lührs, ... Interactive Journal of Medical Research 5 (3), e5822, 2016 | 20 | 2016 |
| Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany A Babac, M Frank, F Pauer, S Litzkendorf, D Rosenfeldt, V Lührs, L Biehl, ... BMC health services research 18, 1-14, 2018 | 17 | 2018 |
| Kidney injury associated with COVID-19 infection and vaccine: A narrative review ICR Pacheco, DMN Costa, DS Sousa, N Salgado Filho, GEB Silva, ... Frontiers in Medicine 9, 956158, 2022 | 15 | 2022 |
| Travel‐acquired subcutaneous Sparganum proliferum infection diagnosed by molecular methods F Schauer, S Poppert, K Technau‐Hafsi, M Mockenhaupt, B Muntau, ... British Journal of Dermatology 170 (3), 741-743, 2014 | 13 | 2014 |
| Natural history and clinical outcome of junctional epidermolysis bullosa generalized intermediate due to a LAMA3 mutation A Reimer, A Schwieger‐Briel, Y He, J Leppert, F Schauer, D Kiritsi, ... British Journal of Dermatology 178 (4), 973-975, 2018 | 12 | 2018 |
| Plectin in skin fragility disorders D Kiritsi, L Tsakiris, F Schauer Cells 10 (10), 2738, 2021 | 11 | 2021 |
| Radiation-associated pemphigus vulgaris in a patient with preceding malignancy: treatment with rituximab as a valuable option F Schauer, N Ishii, M Mockenhaupt, L Bruckner-Tuderman, T Hashimoto, ... Frontiers in Immunology 10, 3116, 2020 | 10 | 2020 |
| Skin inflammation associated with arthritis, synovitis and enthesitis. Part 1: psoriatic arthritis, SAPHO syndrome, Still's disease, Behçet's disease CK Huhn, F Schauer, CM Schempp, N Venhoff, S Finzel JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17 (1), 43-64, 2019 | 9 | 2019 |
| A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid F Schauer, JS Kern, O Virtic, K Technau‐Hafsi, F Meiss, K Thoma, ... British Journal of Dermatology 180 (1), 231-232, 2019 | 7 | 2019 |
